Guilford Gliadel Glioma Trial Shows Consistent Modest Benefit – Cmte.
Executive Summary
Guilford's Gliadel Wafer demonstrates a consistent, if modest, benefit in treatment of newly diagnosed malignant glioma, FDA's Oncologic Drugs Advisory Committee concluded